Head-To-Head Contrast: OptimizeRx (NASDAQ:OPRX) vs. Arcturis Data (OTCMKTS:SSYNF)

OptimizeRx (NASDAQ:OPRX) and Arcturis Data (OTCMKTS:SSYNF) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Earnings and Valuation

This table compares OptimizeRx and Arcturis Data”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	1.35	$5.13 million	$0.23	34.22
Arcturis Data	N/A	N/A	N/A	N/A	N/A

OptimizeRx has higher revenue and earnings than Arcturis Data.

Profitability

This table compares OptimizeRx and Arcturis Data’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Arcturis Data	N/A	N/A	N/A

Insider & Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for OptimizeRx and Arcturis Data, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Arcturis Data	0	0	0	0	0.00

OptimizeRx presently has a consensus price target of $11.43, suggesting a potential upside of 45.22%. Given OptimizeRx’s stronger consensus rating and higher possible upside, research analysts plainly believe OptimizeRx is more favorable than Arcturis Data.

Summary

OptimizeRx beats Arcturis Data on 9 of the 9 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Arcturis Data

Arcturis Data Limited, a data company, uses data to support the discovery and development of new medicines. It supports the delivery of research across various phases of the clinical development pipeline covering various conditions and treatment types. The company translates patient pathways to support clinical development, inform policy, and advance research. It collaborates with research and industry experts to create disease-specific datasets. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Kidlington, the United Kingdom.